Alyeska Investment Group’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
Alyeska Investment Group's BSX Position: Q1 2026 in Review
Alyeska Investment Group sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 237,862 shares — an estimated $22.7M sold.
Alyeska Investment Group first reported a position in BSX in Q4 2016 and held it in 13 quarters. The position peaked at $147M in Q4 2024. 1,681 funds tracked by Wall St. Rank hold BSX as of Q1 2026.
- Alyeska Investment Group reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
- Alyeska Investment Group sold 237,862 Boston Scientific shares in Q1 2026, an estimated $22.7M.
- Alyeska Investment Group first reported a position in Boston Scientific in Q4 2016 and held it in 13 quarters.
- Alyeska Investment Group's Boston Scientific position peaked at $147M in Q4 2024.
- 1,681 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.
Based on Alyeska Investment Group's 13F filing for Q1 2026, filed 15 May 2026.